Home > Healthcare > Medical Devices > Diagnostic Devices > U.S. PET-CT Scanner Market
U.S. PET-CT Scanner Market Size
- Report ID: GMI12073
- Published Date: Oct 2024
- Report Format: PDF
U.S. PET-CT Scanner Market Size
U.S. PET-CT scanner market size was valued at around USD 864 million in 2023 and is estimated to grow at 5.9% CAGR from 2024 to 2032. PET-CT scanner is a medical imaging device that combines positron emission tomography (PET) and computed tomography (CT) technologies into a single machine.
PET scans detect the metabolic activity of cells by using radioactive tracers, while CT scans provide detailed structural images. This simultaneous acquisition of functional and anatomical information helps in enhancing the diagnostic capabilities, particularly in oncology, cardiology, and neurology.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| U.S. PET-CT Scanner Market Size in 2023: | USD 864 Million |
| Forecast Period: | 2024 – 2032 |
| Forecast Period 2024 – 2032 CAGR: | 5.9% |
| 2024 – 2032 Value Projection: | USD 1.4 Billion |
| Historical Data for: | 2021-2023 |
| No. of Pages: | 112 |
| Tables, Charts & Figures: | 66 |
| Segments covered: | Type, Modality, Slice Count, Application, End Use, and Zone |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Rapid innovations, marked by frequent product launches aimed at enhancing imaging quality and reducing scan times, are propelling the growth of the U.S. PET-CT scanner market. Noteworthy advancements, such as the introduction of digital PET scanners boasting superior sensitivity and resolution, are set to significantly bolster this market's expansion. Furthermore, the U.S. healthcare system's focus on personalized medicine has spurred a heightened reliance on PET scans, especially for precise tumor localization and monitoring treatment responses.
Concurrently, cancer stands as the second leading cause of death in the U.S. The American Cancer Society forecasts around 2,001,140 new cancer cases and over 611,720 cancer-related deaths in 2024. This rising incidence underscores the urgency for enhanced diagnostic tools, propelling the demand and growth of the PET-CT scanner market.
Additionally, collaborations between technology companies and healthcare providers are driving research into new radiotracers. These radiotracers can target specific diseases more effectively, thus expanding the clinical applications of PET technology. For instance, in February 2024, IONETIX, a leader in cyclotron technology and isotope production, announced a partnership with Provision Diagnostic Imaging in Knoxville. The collaboration centered on the use of IONETIX's on-site production of N-13 Ammonia for cardiac PET/CT imaging. Provision Diagnostic Imaging, known for introducing advanced diagnostic technologies to East Tennessee, integrated this innovation to enhance its cardiac diagnostic services.
Frequently Asked Questions (FAQ) :
U.S. PET-CT Scanner Market Scope
